These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29549349)

  • 1. Cannabinoid-induced increase of quantal size and enhanced neuromuscular transmission.
    Morsch M; Protti DA; Cheng D; Braet F; Chung RS; Reddel SW; Phillips WD
    Sci Rep; 2018 Mar; 8(1):4685. PubMed ID: 29549349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.
    Mulè F; Amato A; Baldassano S; Serio R
    Pharmacol Res; 2007 Sep; 56(3):185-92. PubMed ID: 17656103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a modulatory role of cannabinoids on the excitatory NANC neurotransmission in mouse colon.
    Mulè F; Amato A; Baldassano S; Serio R
    Pharmacol Res; 2007 Aug; 56(2):132-9. PubMed ID: 17574859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Safety Factor for Neuromuscular Transmission: Effects of Dimethylsulphoxide, Cannabinoids and Synaptic Homeostasis.
    Odierna GL; Phillips WD
    J Neuromuscul Dis; 2021; 8(5):831-844. PubMed ID: 34334412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cannabinoids on synaptic transmission in the frog neuromuscular junction.
    Sánchez-Pastor E; Trujillo X; Huerta M; Andrade F
    J Pharmacol Exp Ther; 2007 May; 321(2):439-45. PubMed ID: 17267583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposing effects of cannabinoids and vanilloids on evoked quantal release at the frog neuromuscular junction.
    Silveira PE; Silveira NA; Morini Vde C; Kushmerick C; Naves LA
    Neurosci Lett; 2010 Apr; 473(2):97-101. PubMed ID: 20176082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-beta2 alters the characteristics of the neuromuscular junction by regulating presynaptic quantal size.
    Fong SW; McLennan IS; McIntyre A; Reid J; Shennan KI; Bewick GS
    Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13515-9. PubMed ID: 20624974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids.
    Hoffman AF; Lupica CR
    J Neurophysiol; 2001 Jan; 85(1):72-83. PubMed ID: 11152707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors.
    Melis M; Pistis M; Perra S; Muntoni AL; Pillolla G; Gessa GL
    J Neurosci; 2004 Jan; 24(1):53-62. PubMed ID: 14715937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of synaptic inputs by constitutively released endocannabinoids and exogenous cannabinoids.
    Hentges ST; Low MJ; Williams JT
    J Neurosci; 2005 Oct; 25(42):9746-51. PubMed ID: 16237178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential neuromodulatory role of endocannabinoids in the rodent trigeminal sensory ganglion and cerebral cortex relevant to pain processing.
    Eroli F; Loonen ICM; van den Maagdenberg AMJM; Tolner EA; Nistri A
    Neuropharmacology; 2018 Mar; 131():39-50. PubMed ID: 29225040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depolarization-induced release of endocannabinoids by murine dorsal motor nucleus of the vagus nerve neurons differentially regulates inhibitory and excitatory neurotransmission.
    Roux J; Wanaverbecq N; Jean A; Lebrun B; Trouslard J
    Neuropharmacology; 2009 Jun; 56(8):1106-15. PubMed ID: 19332082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromuscular transmission in neonatal mice injected with serum globulin of myasthenia gravis patients.
    Pagala MK; Tada S; Namba T; Grob D
    Neurology; 1982 Jan; 32(1):12-7. PubMed ID: 6275304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoids Modulate Light Signaling in ON-Sustained Retinal Ganglion Cells of the Mouse.
    Middleton TP; Huang JY; Protti DA
    Front Neural Circuits; 2019; 13():37. PubMed ID: 31164809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
    Accorsi-Mendonça D; Almado CE; Dagostin AL; Machado BH; Leão RM
    Brain Res; 2008 Mar; 1200():1-9. PubMed ID: 18308297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CB1 cannabinoid receptor mediates glutamatergic synaptic suppression in the hippocampus.
    Takahashi KA; Castillo PE
    Neuroscience; 2006; 139(3):795-802. PubMed ID: 16527424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle specific kinase autoantibodies cause synaptic failure through progressive wastage of postsynaptic acetylcholine receptors.
    Morsch M; Reddel SW; Ghazanfari N; Toyka KV; Phillips WD
    Exp Neurol; 2012 Oct; 237(2):286-95. PubMed ID: 22789393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the effects of cannabinoids on synaptic transmission between basket and Purkinje cells in the cerebellar cortex of the rat.
    Szabo B; Than M; Thorn D; Wallmichrath I
    J Pharmacol Exp Ther; 2004 Sep; 310(3):915-25. PubMed ID: 15123767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro.
    Vaughan CW; Connor M; Bagley EE; Christie MJ
    Mol Pharmacol; 2000 Feb; 57(2):288-95. PubMed ID: 10648638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models.
    van der Pijl EM; van Putten M; Niks EH; Verschuuren JJ; Aartsma-Rus A; Plomp JJ
    Eur J Neurosci; 2016 Jun; 43(12):1623-35. PubMed ID: 27037492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.